ArticleEndocrine connections2025

Prevalence and risk factors of eligibility for anti-osteoporosis medication in a cohort of men ≥50 years and postmenopausal women who had already experienced bariatric surgery.

Thomas Flament et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.